SG17993G - Novel pharmaceutical use of(nva)2-cyclosporine - Google Patents

Novel pharmaceutical use of(nva)2-cyclosporine

Info

Publication number
SG17993G
SG17993G SG17993A SG17993A SG17993G SG 17993 G SG17993 G SG 17993G SG 17993 A SG17993 A SG 17993A SG 17993 A SG17993 A SG 17993A SG 17993 G SG17993 G SG 17993G
Authority
SG
Singapore
Prior art keywords
nva
cyclosporine
pharmaceutical use
novel pharmaceutical
novel
Prior art date
Application number
SG17993A
Other languages
English (en)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419716A external-priority patent/GB8419716D0/en
Priority claimed from GB848419715A external-priority patent/GB8419715D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SG17993G publication Critical patent/SG17993G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG17993A 1984-08-02 1993-02-17 Novel pharmaceutical use of(nva)2-cyclosporine SG17993G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848419716A GB8419716D0 (en) 1984-08-02 1984-08-02 Organic compounds
GB848419715A GB8419715D0 (en) 1984-08-02 1984-08-02 Organic compounds

Publications (1)

Publication Number Publication Date
SG17993G true SG17993G (en) 1993-04-16

Family

ID=26288061

Family Applications (1)

Application Number Title Priority Date Filing Date
SG17993A SG17993G (en) 1984-08-02 1993-02-17 Novel pharmaceutical use of(nva)2-cyclosporine

Country Status (8)

Country Link
EP (2) EP0170623B1 (de)
AU (1) AU581010B2 (de)
CY (1) CY1697A (de)
DE (2) DE3580717D1 (de)
DK (1) DK348385A (de)
HK (1) HK106393A (de)
PH (1) PH21235A (de)
SG (1) SG17993G (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) * 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
US7081445B2 (en) 1989-02-20 2006-07-25 Novartis Ag Cyclosporin galenic forms
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
WO1993023010A1 (en) 1992-05-13 1993-11-25 Sandoz Ltd. Ophthalmic compositions containing a cyclosporin
ES2168271T3 (es) 1992-09-25 2002-06-16 Novartis Ag Composiciones farmaceuticas que contienen ciclosporinas.
PT697881E (pt) * 1993-04-20 2002-10-31 Novartis Ag Novas composicoes farmaceuticas contendo ciclosporina para administracao oral
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
DE19544507B4 (de) 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'－脱氧－3'－氧代－MeBmt]'环孢菌素制备方法
ES2229473T3 (es) 1997-01-30 2005-04-16 Novartis Ag Composiciones farmaceuticas sin aceite que contienen ciclosporina a.
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
DE10356378A1 (de) * 2003-12-03 2005-06-30 Continental Aktiengesellschaft Verfahren zur Funktionssteuerung eines elektronischen Fahrstabilitätsprogramms für ein Kraftfahrzeug
WO2009042892A1 (en) * 2007-09-26 2009-04-02 Oregon Health & Science University Cyclic undecapeptides and derivatives as multiple sclerosis therapies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d

Also Published As

Publication number Publication date
HK106393A (en) 1993-10-15
AU4563185A (en) 1986-02-06
EP0170623B1 (de) 1990-11-28
EP0365044A3 (de) 1990-08-22
DK348385A (da) 1986-02-03
PH21235A (en) 1987-08-21
DE3526545A1 (de) 1986-02-13
EP0365044A2 (de) 1990-04-25
EP0170623A3 (en) 1987-10-28
DE3580717D1 (de) 1991-01-10
AU581010B2 (en) 1989-02-09
EP0170623A2 (de) 1986-02-05
CY1697A (en) 1994-01-14
DK348385D0 (da) 1985-07-31

Similar Documents

Publication Publication Date Title
GB2231265B (en) Therapeutic use of serotonin-antagonists
PH21235A (en) Novel pharmaceutical use of (nva)2-cyclosporins
IL75533A0 (en) Preparation of heteroaryloxyacetamides
GB8507789D0 (en) Preparation of 2-amino-s-triazines
IL80305A0 (en) Preparation of epsilon-butyrolactams
GB8529729D0 (en) Preparation of fish-noodles
AU585890B2 (en) Pharmaceutical use of somatostatin analogues
IL76249A0 (en) Preparation of fluoroformates
IL78379A (en) Preparation of 2-mercaptobenzoxazoles
IL80657A0 (en) Preparation of monochloropinacolone
IL74168A0 (en) 1alpha-hydroxyvitamin d2 analogs and pharmaceutical compositions containing them
DE3566540D1 (en) Preparation of fluoropyridines
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8422162D0 (en) Preparation of alkyfurans
GB8520403D0 (en) Preparation of aminolactone
IL78977A (en) Preparation of alkyloxiranes
ZA855872B (en) Novel pharmaceutical use of(nva)2-and dihydro-(val)2-cyclosporins
GB8601724D0 (en) Application of tetracyano-quinodimethanes
GB8708603D0 (en) Preparation of()-13-norfaranal
IL75926A0 (en) Somatostatin analogs and pharmaceutical compositions containing them
DE3566532D1 (en) Preparation of 4-fluorophenols
GB8802972D0 (en) Triperfluoroalkylamines & preparation of same
GB8613066D0 (en) Protection of proteins &c
GB8704561D0 (en) Application of tetrathiafulvalenes
IL91357A0 (en) Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides